Investor Presentaiton

||| Operations and performance Operational performance Logistics services Broad capillarity and distribution capacity are fundamental com- petitive advantages for Viveo, which add value to our ecosystem and ensure excellence in customer service. Through Healthlog. our logistics services platform, we reach several regions of Brazil, including the most remote, and achieve superior results, among which include: High level of Service and national coverage with our own freight fleet; A wide structure allocated in strategic regions; > Storage services for hospitals and the use of Vendor Man- aged Inventory (VMI) with customers and suppliers; Highest level of Service in Brazil, able to provide service to 71% of the country's hospital beds in 24 hours, 24% in 48 hours, and 5% in 72 hours with service levels compared to the main North American distributors; and The use of the Warehouse Management System (WMS) in distribution centers and cell phones in all vehicles in the fleet, with tools integrated into the technological environ- ment of our customers. D2P (Direct to Patient) The company developed the D2P platform (Direct to Patient) aiming to offer agile, simple, and affordable alternatives for patients to have access to medicines and medical materials at home or wherever they wish. Due to existing business relationships and its wide distribution capacity, Viveo is in a differentiated position to operate in this segment, which in 2021 had some big high- lights, such as: Due to our provisions for healthcare insurance plans and beneficiaries that require special medication, patients benefited from over 22% of medication release errors being avoided, as well as 2% of adverse reactions from detected and treated treatments, and a 4.6% reduction in unnecessary operating costs was achieved; 92-point patient NPS, relating to the care of individuals (patients) by the business ecosys- tem; and More than 5.7 thousand medical prescriptions and 41 thousand medications were ana- lyzed, followed by 700 suggestions for pharmaceutical adjustments based on pharmaco- therapy, with 70% being accepted by the patient and doctor. Far.me - São Paulo (SP) viveo 40 Sustainability Report 2021 far.me

View entire presentation